<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0740451" disease_type="Disease or Syndrome" abbrv="">granulomatous disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGD</z:e>) is characterized by <z:hpo ids='HP_0002719'>recurrent infections</z:hpo> and granuloma formation </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, we have observed a number of diverse autoimmune conditions in our <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGD</z:e> population, suggesting that patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGD</z:e> are at an elevated risk for development of <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, we describe <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, recurrent <z:hpo ids='HP_0001698'>pericardial effusion</z:hpo>, juvenile idiopathic <z:hpo ids='HP_0001369'>arthritis</z:hpo>, <z:hpo ids='HP_0000794'>IgA nephropathy</z:hpo>, <z:e sem="disease" ids="C0024137" disease_type="Disease or Syndrome" abbrv="">cutaneous lupus erythematosus</z:e>, and autoimmune <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">pulmonary disease</z:e> in the setting of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The presence and type of <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> have important treatment implications for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGD</z:e> </plain></SENT>
</text></document>